Clicky

Innate Pharma S.A(IDD) News

Date Title
Aug 4 Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025
Jul 31 Mycosis Fungoides Clinical Trials Market Landscape Report 2025 Featuring Pfizer, Bristol-Myers Squibb, Kirin, Takeda, Johnson & Johnson, Merck, Soligenix, Eisai, Novartis, ICON
Jul 29 Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference
Jun 13 Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress
May 27 Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences
May 23 Outcome of Innate Pharma’s 2025 Annual General Meeting
May 23 Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides
Feb 17 Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome